Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapies.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 17 04 2020
revised: 16 05 2020
accepted: 17 05 2020
pubmed: 9 6 2020
medline: 7 7 2021
entrez: 8 6 2020
Statut: ppublish

Résumé

Retinal diseases constitute a genetically and phenotypically diverse group of clinical conditions leading to vision impairment or blindness with limited treatment options. Advances in reprogramming of somatic cells to induced pluripotent stem cells and generation of three-dimensional organoids resembling the native retina offer promising tools to interrogate disease mechanisms and evaluate potential therapies for currently incurable retinal neurodegeneration. Next-generation sequencing, single-cell analysis, advanced electrophysiology, and high-throughput screening approaches are expected to greatly expand the utility of stem cell-derived retinal cells and organoids for developing personalized treatments. In this review, we discuss the current status and future potential of combining retinal organoids as human models with recent technologies to advance the development of gene, cell, and drug therapies for retinopathies.

Identifiants

pubmed: 32506758
doi: 10.1002/stem.3239
pmc: PMC7586922
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1206-1215

Subventions

Organisme : Intramural NIH HHS
ID : ZIA EY000450
Pays : United States
Organisme : NEI NIH HHS
ID : ZIAEY000546
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA EY000474
Pays : United States
Organisme : NEI NIH HHS
ID : ZIAEY000474
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA EY000546
Pays : United States
Organisme : NEI NIH HHS
ID : ZIAEY000450
Pays : United States

Informations de copyright

©2020 The Authors. Stem Cells published by Wiley Periodicals LLC on behalf of AlphaMed Press 2020.

Références

Hum Gene Ther. 2018 Oct;29(10):1124-1139
pubmed: 29580100
Stem Cell Reports. 2016 May 10;6(5):743-756
pubmed: 27132890
Nature. 2020 Feb;578(7793):142-148
pubmed: 31996853
Nat Commun. 2016 Nov 30;7:13537
pubmed: 27901042
Nat Med. 2016 Oct;22(10):1101-1107
pubmed: 27571349
Cell Stem Cell. 2016 Jun 2;18(6):769-81
pubmed: 27151457
Lancet. 2012 Feb 25;379(9817):713-20
pubmed: 22281388
Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8232-7
pubmed: 23150612
Nature. 2019 Oct;574(7778):418-422
pubmed: 31619793
Cell Stem Cell. 2009 Jan 9;4(1):73-9
pubmed: 19128794
Cell Stem Cell. 2012 Jun 14;10(6):771-785
pubmed: 22704518
Stem Cells. 2015 Dec;33(12):3504-18
pubmed: 26235913
Curr Eye Res. 2020 Mar;45(3):385-396
pubmed: 31794277
Stem Cells. 2014 Jun;32(6):1480-92
pubmed: 24532057
Stem Cell Reports. 2019 May 14;12(5):906-919
pubmed: 30956116
Nat Genet. 2016 Feb;48(2):134-43
pubmed: 26691988
Stem Cells. 2020 Oct 1;38(10):1206-1215
pubmed: 32506758
Sci Transl Med. 2017 Dec 20;9(421):
pubmed: 29263231
Stem Cells. 2019 May;37(5):593-598
pubmed: 30548510
Sci Rep. 2018 Oct 23;8(1):15664
pubmed: 30353124
Stem Cells Transl Med. 2019 Jul;8(7):694-706
pubmed: 30916455
Nat Biotechnol. 2018 Apr;36(4):328-337
pubmed: 29553577
Nature. 2012 May 3;485(7396):99-103
pubmed: 22522934
Sci Rep. 2017 Apr 10;7(1):766
pubmed: 28396597
Stem Cell Reports. 2018 Mar 13;10(3):1059-1074
pubmed: 29503091
Mol Ther Nucleic Acids. 2018 Sep 7;12:730-740
pubmed: 30114557
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E81-90
pubmed: 26699487
Mol Vis. 2019 Nov 11;25:663-678
pubmed: 31814692
Mol Cell Proteomics. 2007 Aug;6(8):1299-317
pubmed: 17494944
Cell Rep. 2018 Oct 16;25(3):611-623.e6
pubmed: 30332642
Nat Genet. 2019 Apr;51(4):606-610
pubmed: 30742112
PLoS One. 2009 Oct 14;4(10):e7467
pubmed: 19826483
Stem Cell Res Ther. 2018 Jun 13;9(1):156
pubmed: 29895313
Cell Rep. 2017 Jul 11;20(2):384-396
pubmed: 28700940
Nature. 2019 Jan;565(7740):505-510
pubmed: 30651639
Int J Ophthalmol. 2018 Jan 18;11(1):117-134
pubmed: 29376001
Stem Cell Reports. 2018 Jan 9;10(1):300-313
pubmed: 29233554
Stem Cell Reports. 2018 Apr 10;10(4):1267-1281
pubmed: 29526738
Nat Methods. 2018 Aug;15(8):631-639
pubmed: 30038414
Stem Cell Reports. 2018 Apr 10;10(4):1282-1293
pubmed: 29576537
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16698-703
pubmed: 19706890
Exp Eye Res. 2015 Sep;138:32-41
pubmed: 26093275
Development. 2019 Jan 9;146(1):
pubmed: 30567931
J Neurosci. 2011 Aug 3;31(31):11118-25
pubmed: 21813673
Nat Commun. 2018 Oct 12;9(1):4234
pubmed: 30315276
Stem Cell Reports. 2019 Oct 8;13(4):747-760
pubmed: 31543471
Dev Cell. 2017 Dec 18;43(6):763-779.e4
pubmed: 29233477
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10824-10833
pubmed: 31072937
Nat Commun. 2016 Oct 04;7:13028
pubmed: 27701381
Elife. 2019 Aug 27;8:
pubmed: 31451149
Nature. 2006 Nov 9;444(7116):203-7
pubmed: 17093405
Sci Adv. 2020 Feb 07;6(6):eaay5247
pubmed: 32083182
Stem Cells Transl Med. 2012 Jun;1(6):503-9
pubmed: 23197854
Nat Commun. 2015 Feb 19;6:6286
pubmed: 25695148
Prog Brain Res. 2017;231:225-244
pubmed: 28554398
Nature. 2017 May 4;545(7652):48-53
pubmed: 28445462
Nature. 2011 Apr 7;472(7341):51-6
pubmed: 21475194
Nat Commun. 2016 Oct 04;7:13029
pubmed: 27701378
Stem Cell Investig. 2018 Oct 10;5:33
pubmed: 30498744
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(5):ORSFl1-ORSFl11
pubmed: 27116668
Sci Rep. 2016 Jul 13;6:29784
pubmed: 27405580
Curr Biol. 2008 Dec 23;18(24):1917-21
pubmed: 19084410
Nat Commun. 2014 Jun 10;5:4047
pubmed: 24915161
Trends Mol Med. 2018 Aug;24(8):669-681
pubmed: 29983335
Am J Hum Genet. 2017 Jan 5;100(1):75-90
pubmed: 28041643
Nat Rev Neurosci. 2010 Aug;11(8):563-76
pubmed: 20648062
Neuron. 2019 Jun 19;102(6):1111-1126.e5
pubmed: 31128945
Cell Stem Cell. 2017 May 4;20(5):635-647.e7
pubmed: 28132833
Science. 2018 Oct 12;362(6411):
pubmed: 30309916
Stem Cell Reports. 2017 Dec 12;9(6):1898-1915
pubmed: 29153988
Mol Vis. 2012;18:920-36
pubmed: 22539871
Stem Cell Reports. 2014 Apr 24;2(5):662-74
pubmed: 24936453
Stem Cell Reports. 2014 Jan 23;2(2):205-18
pubmed: 24527394
Cell Stem Cell. 2018 Jun 01;22(6):834-849
pubmed: 29859174
EMBO J. 2019 Sep 16;38(18):e100811
pubmed: 31436334
Stem Cell Reports. 2017 Sep 12;9(3):820-837
pubmed: 28844659
Mol Vis. 2020 Mar 03;26:97-105
pubmed: 32174751
Am J Ophthalmol. 2002 Apr;133(4):544-50
pubmed: 11931789
Nat Commun. 2018 Dec 4;9(1):5167
pubmed: 30514835
Stem Cell Reports. 2017 Jun 6;8(6):1659-1674
pubmed: 28552606
PLoS One. 2011 Feb 10;6(2):e17084
pubmed: 21347327
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Nature. 2020 May;581(7806):83-88
pubmed: 32376950
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8428-36
pubmed: 26747773
Stem Cell Reports. 2019 Nov 12;13(5):891-905
pubmed: 31631019
Transl Sci Rare Dis. 2019 Jul 04;4(1-2):97-115
pubmed: 31763178
Stem Cell Reports. 2019 Nov 12;13(5):906-923
pubmed: 31668851
Nat Biotechnol. 2008 Feb;26(2):215-24
pubmed: 18246062
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8518-23
pubmed: 24912154
Development. 2017 Oct 15;144(20):3698-3705
pubmed: 28870990
Stem Cells. 2018 Oct;36(10):1535-1551
pubmed: 30004612
Cell Rep. 2020 Feb 4;30(5):1644-1659.e4
pubmed: 32023475

Auteurs

Kamil Kruczek (K)

Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.

Anand Swaroop (A)

Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH